HealthTree Logo
search more_vert
person Sign In / Create Account

Clinical Expertise

  • Multiple Myeloma 


As leading researcher in multiple myeloma, Dr. Phillipe Moreau is head of the unit for early phase 1 and phase 2 trials in clinical hematology at the University Hospital of Nantes and was instrumental in clinical trials for the new proteasome inhibitor ixazomib. Additionally, he was a member of the organizing committee for the 2011 International Myeloma Workshop, in Paris. Dr. Phillipe Moreau is currently a member of the administration council of the Intergroupe Francophone du Myélome (IFM), and he was chairman of the IFM from 2006 through 2009.


University Hospital Hôtel-dieu: 1 Pl. Alexis-Ricordeau, 44000 Nantes, France

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube